Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P C Walsh

Showing results (341-350 of 350) with videos related to

Pageof 35
Sort By:
You have reached the last page of results.This site can display upto 350 results.
Urology|August 5, 2000
Comparison of percent free PSA, PSA density, and age-specific PSA cutoffs for prostate cancer detection and stagingW J Catalona, P C Southwick, K M Slawin, et al.
Cancer Genetics and Cytogenetics|October 16, 2002
Germline sequence variants of the LZTS1 gene are associated with prostate cancer riskGregory A Hawkins, Josyf C Mychaleckyj, Siqun L Zheng, et al.
Human Genetics|May 31, 2001
Linkage of prostate cancer susceptibility loci to chromosome 1J Xu, S L Zheng, B Chang, et al.
The Journal of Clinical Investigation|May 1, 1983
Spontaneous benign prostatic hyperplasia in the beagle. Age-associated changes in serum hormone levels, and the morphology and secretory function of the canine prostateC B Brendler, S J Berry, L L Ewing, et al.
Oncology (Williston Park, N.Y.)|February 24, 2001
NCCN Practice Guidelines for Prostate CancerR R Bahnson, G E Hanks, R P Huben, et al.
American Journal of Human Genetics|July 10, 2001
Linkage and association studies of prostate cancer susceptibility: evidence for linkage at 8p22-23J Xu, S L Zheng, G A Hawkins, et al.
Urology|March 4, 2000
Percentage of free PSA in black versus white men for detection and staging of prostate cancer: a prospective multicenter clinical trialW J Catalona, A W Partin, K M Slawin, et al.
JAMA|May 30, 1998
Use of the percentage of free prostate-specific antigen to enhance differentiation of prostate cancer from benign prostatic disease: a prospective multicenter clinical trialW J Catalona, A W Partin, K M Slawin, et al.
American Journal of Human Genetics|March 20, 2001
Evaluation of linkage and association of HPC2/ELAC2 in patients with familial or sporadic prostate cancerJ Xu, S L Zheng, J D Carpten, et al.
Science (New York, N.Y.)|November 22, 1996
Major susceptibility locus for prostate cancer on chromosome 1 suggested by a genome-wide searchJ R Smith, D Freije, J D Carpten, et al.
Pageof 35

Showing results (341-350 of 350) with videos related to

Sort By:
Pageof 35
You have reached the last page of results.This site can display upto 350 results.
Urology|August 5, 2000
Comparison of percent free PSA, PSA density, and age-specific PSA cutoffs for prostate cancer detection and stagingW J Catalona, P C Southwick, K M Slawin, et al.
Cancer Genetics and Cytogenetics|October 16, 2002
Germline sequence variants of the LZTS1 gene are associated with prostate cancer riskGregory A Hawkins, Josyf C Mychaleckyj, Siqun L Zheng, et al.
Human Genetics|May 31, 2001
Linkage of prostate cancer susceptibility loci to chromosome 1J Xu, S L Zheng, B Chang, et al.
The Journal of Clinical Investigation|May 1, 1983
Spontaneous benign prostatic hyperplasia in the beagle. Age-associated changes in serum hormone levels, and the morphology and secretory function of the canine prostateC B Brendler, S J Berry, L L Ewing, et al.
Oncology (Williston Park, N.Y.)|February 24, 2001
NCCN Practice Guidelines for Prostate CancerR R Bahnson, G E Hanks, R P Huben, et al.
American Journal of Human Genetics|July 10, 2001
Linkage and association studies of prostate cancer susceptibility: evidence for linkage at 8p22-23J Xu, S L Zheng, G A Hawkins, et al.
Urology|March 4, 2000
Percentage of free PSA in black versus white men for detection and staging of prostate cancer: a prospective multicenter clinical trialW J Catalona, A W Partin, K M Slawin, et al.
JAMA|May 30, 1998
Use of the percentage of free prostate-specific antigen to enhance differentiation of prostate cancer from benign prostatic disease: a prospective multicenter clinical trialW J Catalona, A W Partin, K M Slawin, et al.
American Journal of Human Genetics|March 20, 2001
Evaluation of linkage and association of HPC2/ELAC2 in patients with familial or sporadic prostate cancerJ Xu, S L Zheng, J D Carpten, et al.
Science (New York, N.Y.)|November 22, 1996
Major susceptibility locus for prostate cancer on chromosome 1 suggested by a genome-wide searchJ R Smith, D Freije, J D Carpten, et al.
Pageof 35